Athersys Announces Authorization of Stem Cell Clinical Trial for Stroke in the United Kingdom

Athersys, Inc. announced today that the Medicines and Healthcare products Regulatory Agency has approved Athersys' application to expand its ongoing Phase 2 study evaluating the administration of MultiStem therapy to patients who have suffered an ischemic stroke.

http://www.drugs.com/clinical_trials/athersys-announces-authorization-stem-cell-clinical-trial-stroke-united-kingdom-15416.html